All In MedTech

Device Trial Radar · NCT07681154

Pilot Study Evaluating Catheter Directed Thrombolysis Device in Acute Intermediate Risk Pulmonary Embolism

Pilot Study to Evaluate the Safety and Feasibility of the Flow Medical Catheter for Catheter-Directed Thrombolysis in Acute Intermediate-Risk Pulmonary Embolism

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

May 2027

Study completion Jun 2027

Sponsor

Lead sponsor
Flow Medical Solutions, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 2, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a pilot study of the Flow Medical Catheter, a catheter-based device used to deliver clot-dissolving medication directly to a blood clot in the lungs (pulmonary embolism). The study evaluates whether the device can be used safely and as intended in adults with intermediate-risk acute pulmonary embolism. All participants receive treatment with the study device; there is no comparison group.

Conditions

  • Pulmonary Embolism (PE)
  • Pulmonary Embolism With Right Ventricle Enlargement

Interventions

  • Thrombolysis CatheterDevice

    Catheter-directed thrombolysis is performed using the Flow Medical Catheter to deliver a thrombolytic agent directly into the pulmonary arteries. The device is positioned at the target site, and thrombolytic infusion is delivered per the study protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of device-related serious adverse events (SAEs)Time frame: 72 hours post procedure

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Regional de Talca (HRT)

    Talca, Maule Region, Chile

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.